Press Releases

Press Releases

Filters
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
Viatris Statement Regarding the Closing of Global Research and Development Collaboration with Idorsia
Viatris Statement Regarding the Transaction with Insud Pharma
Viatris and Mapi Pharma Statement Regarding New Drug Application for GA Depot
Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration
Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results
Viatris to Participate in 42nd Annual J.P. Morgan Healthcare Conference
Displaying 1 - 10 of 96